Page 13

Feb 20, 2024

CERN announces Small Hadron Collider for home use

Posted by in category: particle physics

CERN has announced that they are to release a cut-down version of their popular Hadron Collider for use in the home.

The Large Hadron Collider was built over twenty years ago, is housed in a 27-kilometre tunnel on the Switzerland – France border, and is used to smash particles together to see what happens.

The facility has proven tremendously successful, having smashed over thirty particles together since it was built.

Feb 20, 2024

WordPress Bricks Theme Under Active Attack: Critical Flaw Impacts 25,000+ Sites

Posted by in category: security

A critical security flaw in the Bricks theme for WordPress is being actively exploited by threat actors to run arbitrary PHP code on susceptible installations.

The flaw, tracked as CVE-2024–25600 (CVSS score: 9.8), enables unauthenticated attackers to achieve remote code execution. It impacts all versions of the Bricks up to and including 1.9.6.

It has been addressed by the theme developers in version released on February 13, 2024, merely days after WordPress security provider Snicco reported the flaw on February 10.

Feb 20, 2024

Anatsa Android malware downloaded 150,000 times via Google Play

Posted by in categories: cybercrime/malcode, finance, mobile phones

The Anatsa banking trojan has been targeting users in Europe by infecting Android devices through malware droppers hosted on Google Play.

Over the past four months, security researchers noticed five campaigns tailored to deliver the malware to users in the UK, Germany, Spain, Slovakia, Slovenia, and the Czech Republic.

Researchers at fraud detection company ThreatFabric noticed an increase of Anatsa activity since November, with at least 150,000 infections.

Feb 20, 2024

Cactus ransomware claim to steal 1.5TB of Schneider Electric data

Posted by in categories: business, cybercrime/malcode, robotics/AI, sustainability

The Cactus ransomware gang claims they stole 1.5TB of data from Schneider Electric after breaching the company’s network last month.

25MB of allegedly stolen were also leaked on the operation’s dark web leak site today as proof of the threat actor’s claims, together with snapshots showing several American citizens’ passports and non-disclosure agreement document scans.

As BleepingComputer first reported, the ransomware group gained access to the energy management and automation giant’s Sustainability Business division on January 17th.

Feb 20, 2024

‘Stepping stone to Mars’: Minimoons may help us become an interplanetary species, says MIT astrophysicist Richard Binzel

Posted by in category: space

MIT researcher Richard Binzel has studied near-Earth asteroids for more than five decades and believes they could one day act as “space filling stations.”

Feb 20, 2024

NASA looking for 4 volunteers to spend a year living and working inside a Mars simulator

Posted by in categories: biotech/medical, health, space travel

Ever wonder what it’s like to live on Mars? Now, you could try out life on the Red Planet – in a simulation run by NASA. The space agency is looking for participants to live on a fake Mars for a full year to help them prepare for human exploration of the planet.

This is the second of three missions, which will have four volunteers living in a 1,700-square-foot Mars simulation, NASA has announced. The missions, called CHAPEA, for Crew Health and Performance Exploration Analog, take place in a 3D-printed Mars habitat at NASA’s Johnson Space Center in Houston, Texas.

The simulation, called the Mars Dune Alpha, simulates a future Mars habitat with separate areas for living and working. It includes four living quarters for each volunteer, a workspace, a medical station, lounge areas and a galley and food growing stations.

Feb 20, 2024

ASCO Gastrointestinal Cancers Symposium 2024

Posted by in categories: biotech/medical, satellites

NEJM Journal Watch Oncology and Hematology Associate Editor David Ilson was on hand at the 2024 ASCO Gastrointestinal Cancers Symposium and highlights the latest research in colorectal, neuroendocrine, and esophagogastric cancers.

Important new studies with the potential to impact clinical practice were presented at the 2024 ASCO Gastrointestinal Cancers Symposium held January 18 to 20 in San Francisco. NEJM Journal Watch Oncology and Hematology Associate Editor David H. Ilson, MD, PhD, was on hand and reports on some of them.


Continue reading “ASCO Gastrointestinal Cancers Symposium 2024” »

Feb 20, 2024

How to detect the deadliest form of cancer

Posted by in categories: biotech/medical, health, neuroscience

Lung cancer is the deadliest of cancers. Screening could save thousands of lives, so why is it not the norm?

Continue reading “How to detect the deadliest form of cancer” »

Feb 20, 2024

New research offers hope to those affected by aggressive brain cancer

Posted by in categories: biotech/medical, life extension, neuroscience

New research from the University of Sussex holds promise for extending life expectancy and enhancing treatment options for a common and aggressive brain cancer affecting thousands in the UK annually and hundreds of thousands globally.

Published in the Journal of Advanced Science, the study revealed that the protein PANK4, previously overlooked, can hinder cancer cells’ response to chemotherapy in glioblastoma, an aggressive form of brain cancer and if the protein is removed, cancer cells respond better to the main chemotherapy drug used globally for the treatment of glioblastoma.

Continue reading “New research offers hope to those affected by aggressive brain cancer” »

Feb 20, 2024

LVHN taking part in clinical trial of revolutionary colorectal cancer treatment that saw 100% remission in patients

Posted by in categories: biotech/medical, health

Memorial Sloan Kettering Cancer Center made waves earlier this year when it announced the completion of a clinical trial that saw colorectal cancer in 18 patients disappear.

The patients received a drug that helped their immune system target and attack cancer cells, driving their cancer into remission and rendering it undetectable within six months.

Now, Lehigh Valley Health Network has joined a select group of networks and hospitals participating in the expanded clinical trial of the drug.

Page 13 of 10,627First1011121314151617Last